Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04966481
Title Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

hypopharynx cancer

oral squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

laryngeal squamous cell carcinoma

Therapies

Cetuximab + Palbociclib

Cetuximab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST